Glycosylation: mechanisms, biological functions and clinical implications

M He, X Zhou, X Wang - Signal Transduction and Targeted Therapy, 2024 - nature.com
Protein post-translational modification (PTM) is a covalent process that occurs in proteins
during or after translation through the addition or removal of one or more functional groups …

Glucose transporters in brain in health and disease

H Koepsell - Pflügers Archiv-European Journal of Physiology, 2020 - Springer
Energy demand of neurons in brain that is covered by glucose supply from the blood is
ensured by glucose transporters in capillaries and brain cells. In brain, the facilitative …

Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology

JC Chatham, J Zhang, AR Wende - Physiological reviews, 2021 - journals.physiology.org
In the mid-1980s, the identification of serine and threonine residues on nuclear and
cytoplasmic proteins modified by a N-acetylglucosamine moiety (O-GlcNAc) via an O …

Analytical and biochemical perspectives of protein O-GlcNAcylation

J Ma, C Wu, GW Hart - Chemical Reviews, 2021 - ACS Publications
Protein O-linked β-N-acetylglucosamine (O-GlcNAc) modification (O-GlcNAcylation) is a
unique monosaccharide modification discovered in the early 1980s. With the technological …

O-GlcNAcylation in health and neurodegenerative diseases

BE Lee, PG Suh, JI Kim - Experimental & Molecular Medicine, 2021 - nature.com
O-GlcNAcylation is a posttranslational modification that adds O-linked β-N-
acetylglucosamine (O-GlcNAc) to serine or threonine residues of many proteins. This protein …

The role of protein glycosylation in Alzheimer disease

S Schedin‐Weiss, B Winblad, LO Tjernberg - The FEBS journal, 2014 - Wiley Online Library
Glycosylation is one of the most common, and the most complex, forms of post‐translational
modification of proteins. This review serves to highlight the role of protein glycosylation in …

Diabetes and Alzheimer's disease crosstalk

D Baglietto-Vargas, J Shi, DM Yaeger, R Ager… - Neuroscience & …, 2016 - Elsevier
Despite intensive research efforts over the past few decades, the mechanisms underlying
the etiology of sporadic Alzheimer's disease (AD) remain unknown. This fact is of major …

The emerging link between O-GlcNAc and Alzheimer disease

Y Zhu, X Shan, SA Yuzwa, DJ Vocadlo - Journal of Biological Chemistry, 2014 - ASBMB
Regional glucose hypometabolism is a defining feature of Alzheimer disease (AD). One
emerging link between glucose hypometabolism and progression of AD is the nutrient …

Implications of glycosylation in Alzheimer's disease

H Haukedal, KK Freude - Frontiers in Neuroscience, 2021 - frontiersin.org
Alzheimer's disease (AD) is the most common cause of dementia, affecting millions of
people worldwide, and no cure is currently available. The major pathological hallmarks of …

O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond

SA Yuzwa, DJ Vocadlo - Chemical Society Reviews, 2014 - pubs.rsc.org
Alzheimer disease (AD) is a growing problem for aging populations worldwide. Despite
significant efforts, no therapeutics are available that stop or slow progression of AD, which …